Word

NOVARTIS

Status

Pending

Status Code

681

Status Date

Wednesday, April 10, 2024

Serial Number

98308022

Mark Type

3000

Filing Date

Monday, December 11, 2023

Published for Opposition

Tuesday, May 14, 2024

Trademark Owner History

Novartis AG

Classifications

41 Providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields

9 Downloadable software for the facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields; downloadable software in the nature of a mobile application for facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields

38 Provision of access to e-commerce platforms on the Internet in the medical, pharmaceutical and health fields; Provision of telecommunication services for e-commerce platforms on the Internet and other electronic media in the medical, pharmaceutical and health fields, namely, telecommunication access services.

35 Advertising services; Business management, business organization consultancy and business administration services, all in the medical field; Provision of business information and advisory services relating to e-commerce in the medical field.

44 Providing medical and health information via a website; providing a website featuring information in the field of the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing information in the medical field and information in the field of the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing health information; Providing patients with medical and health information in the medical field.

10 Medical apparatus and instruments for diagnosing and treating cardiovascular diseases; Medical apparatus and instruments for diagnosing and treating dermatological diseases; medical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical apparatus and instruments for diagnosing and treating central nervous system diseases; medical apparatus and instruments for the diagnosis and treatment of gastro-intestinal diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; medical apparatus and instruments for the diagnosis, prevention and treatment of haematology diseases and disorders; medical apparatus and instruments for use in tissue and organ transplantation surgery; medical apparatus and instruments for the diagnosis, prevention and treatment of eye diseases and conditions; medical apparatus and instruments for the diagnosis, prevention and treatment of heart rhythm disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of immune system related diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of kidney diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of diabetes; medical apparatus and instruments for the diagnosis, prevention and treatment of hypertension; medical apparatus and instruments for the diagnosis, prevention and treatment of skin disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of urinary diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of ophthalmological diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of cancer and tumors; medical apparatus and instruments for the diagnosis, prevention and treatment of allergies; medical apparatus and instruments for the diagnosis, prevention and treatment of bone diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of respiratory diseases and asthma; radiological apparatus and instruments for medical use; genetic testing apparatus and instruments for medical use; electromagnetic drug delivery apparatus and instruments for medical use; medical apparatus and instruments for diagnostic radiopharmaceutical use; medical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations; apparatus and instruments for DNA and RNA testing for medical use; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for introducing pharmaceutical preparations into the human body

42 Medical and pharmaceutical research services; pharmaceutical research and development

The mark consists of a stylized presentation of a mortar and pestle to the left of the stylized word "NOVARTIS". The mortar is depicted in orange and yellow, with the top left of the mortar in orange and transitioning to yellow in a counter-clockwise direction. The pestle is shown in blue. The word "NOVARTIS" is presented in capital letters in blue.
The color(s) orange, yellow and blue is/are claimed as a feature of the mark.

Trademark Events

Apr 9, 2024

Approved For Pub - Principal Register

Apr 9, 2024

Examiner's Amendment Entered

Apr 9, 2024

Notification Of Examiners Amendment E-Mailed

Apr 9, 2024

Examiners Amendment E-Mailed

Apr 9, 2024

Examiners Amendment -Written

Apr 8, 2024

Notification Of Non-Final Action E-Mailed

Apr 8, 2024

Non-Final Action E-Mailed

Apr 8, 2024

Non-Final Action Written

Mar 20, 2024

Assigned To Examiner

Mar 12, 2024

Notice Of Design Search Code E-Mailed

Mar 12, 2024

New Application Office Supplied Data Entered

Dec 11, 2023

New Application Entered